CDDC34: A Protein of Interest for Cancer Research (G91057)

Target Name: CCDC34

NCBI ID: G91057

CCDC34

CDDC34: A Protein of Interest for Cancer Research

CCDC34 is a protein that is expressed in various tissues throughout the body, including the brain, lungs, heart, kidneys, and intestines. It is a member of the cancer-related gene family known as the CDKN2A gene family, which is known to be involved in various cellular processes that are important for cancer development and progression.

One of the unique features of CCDC34 is its ability to undergo a process called dance-like movement, which is a type of protein folding that is characterized by the movement of proteins into specific shapes or conformations. This process is thought to be important for the regulation of various cellular processes, including cell signaling and protein-protein interactions.

In addition to its unique protein folding capabilities, CCDC34 is also known for its role in the development and progression of various diseases, including cancer. For example, studies have shown that high levels of CCDC34 are associated with the development of various types of cancer, including breast, ovarian, and prostate cancer.

Another promising aspect of CCDC34 is its potential as a drug target. By targeting CCDC34 with small molecules or other therapeutic agents, researchers may be able to inhibit its activity and reduce the growth and spread of cancer cells. This is an important area of 鈥嬧?媟esearch, as the development of new cancer treatments is a major focus of contemporary medical science.

One approach to targeting CCDC34 is through the use of small molecules that can bind to specific interacting regions on the protein. These small molecules can then inhibit the activity of CCDC34 and prevent it from participating in the regulation of cellular processes.

Another potential approach to targeting CCDC34 is through the use of monoclonal antibodies, which are laboratory-produced proteins that are designed to recognize and bind to a specific protein or set of proteins. By using antibodies against CCDC34, researchers can block its activity in the cell and reduce the growth and spread of cancer cells.

In addition to these therapeutic approaches, researchers are also exploring the use of CCDC34 as a biomarker for the diagnosis and prognosis of various types of cancer. By measuring the levels of CCDC34 in cancer cells or tissue samples, researchers can gain insights into the extent of cancer growth and the effectiveness of different treatments.

Overall, CCDC34 is a protein that is of great interest to researchers because of its unique protein folding capabilities and its role in the development and progression of various diseases. By targeting CCDC34 with small molecules or antibodies, researchers may be able to inhibit its activity and contribute to the development of new cancer treatments.

Protein Name: Coiled-coil Domain Containing 34

Functions: Involved in spermatogenesis. Has a probable role in anterograde intraflagellar transport which is essential for the formation of sperm flagella

The "CCDC34 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC34 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets